GlucoTrack, Inc. Files 8-K

Ticker: GCTK · Form: 8-K · Filed: Jun 13, 2024 · CIK: 1506983

Glucotrack, INC. 8-K Filing Summary
FieldDetail
CompanyGlucotrack, INC. (GCTK)
Form Type8-K
Filed DateJun 13, 2024
Risk Levellow
Pages2
Reading Time2 min
Sentimentneutral

Sentiment: neutral

Topics: 8-K, disclosure, filing

TL;DR

GlucoTrack filed an 8-K, check for updates.

AI Summary

GlucoTrack, Inc. filed an 8-K on June 13, 2024, reporting on a Regulation FD Disclosure and Financial Statements and Exhibits. The company, formerly known as Integrity Applications, Inc., is incorporated in Delaware and headquartered in Rutherford, NJ. The filing does not contain specific financial figures or details about the nature of the disclosure or exhibits.

Why It Matters

This filing indicates GlucoTrack, Inc. is providing updated information or disclosures to the SEC, which could be material for investors to review.

Risk Assessment

Risk Level: low — The filing is a standard procedural disclosure without immediate negative or positive financial implications detailed within the provided text.

Key Players & Entities

FAQ

What specific information is being disclosed under Regulation FD?

The provided text of the 8-K filing does not specify the details of the Regulation FD disclosure.

What are the Financial Statements and Exhibits being filed?

The filing indicates that Financial Statements and Exhibits are included, but their specific content is not detailed in the provided excerpt.

When was GlucoTrack, Inc. formerly known as Integrity Applications, Inc.?

The date of the name change from Integrity Applications, Inc. to GlucoTrack, Inc. was December 3, 2010.

What is the principal executive office address for GlucoTrack, Inc.?

The principal executive offices are located at 301 Rte 17 North, Ste. 800, Rutherford, NJ 07070.

What is the IRS Employer Identification Number for GlucoTrack, Inc.?

The IRS Employer Identification Number for GlucoTrack, Inc. is 98-0668934.

Filing Stats: 486 words · 2 min read · ~2 pages · Grade level 11 · Accepted 2024-06-13 09:22:40

Filing Documents

SIGNATURES

SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Date: June 13, 2024 GLUCOTRACK, INC. By: /s/ Paul Goode Name: Paul Goode Title: Chief Executive Officer

View Full Filing

View this 8-K filing on SEC EDGAR

View on Read The Filing